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What is already known about this topic?  
 Placental function is responsible for significant morbidity and mortality in fetal 
growth restriction, and in monochorionic twin pregnancies complicated by selective 
growth restriction and transfusion conditions.  
 Our ability to diagnose placental dysfunction in utero is currently limited, with 
implications for clinical decision making.  
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 MRI is capable of imaging the whole human placenta at any gestational age, and has 
been shown to demonstrate differences between normally functioning placentas, and 
those with growth restriction. 
 
What does this study add? 
 This review summarises up-to-date research on placental function that has been 
carried out using different MRI modalities.  
 We discuss how combinations of these techniques have much to contribute to fetal 
conditions amenable for therapy such as singletons at high risk for FGR through early 
recognition, appropriate management and monitoring response to treatment; and 
monochorionic twin pregnancies for planning surgery and counselling for selective 
growth restriction and transfusion conditions. 
Data availability Statement: Data sharing is not applicable to this article as no new data 
were created or analysed in this study. 
 
ABSTRACT 
Objective Magnetic Resonance Imaging (MRI) of placental invasion has been part of clinical 
practice for many years. The possibility of being better able to assess placental 
vascularization and function using MRI has multiple potential applications. This review 
summarises up-to-date research on placental function using different MRI modalities. 
 
Method: We discuss how combinations of these MRI techniques have much to contribute to 
fetal conditions amenable for therapy such as singletons at high risk for FGR; and 
monochorionic twin pregnancies for planning surgery and counselling for selective growth 
restriction and transfusion conditions. 
 
Results The whole placenta can easily be visualized on MRI, with a clear boundary against 
the amniotic fluid, and a less clear placental-uterine boundary. Contrasts such as Diffusion 
Weighted Imaging, Relaxometry, Blood Oxygenation Level Dependent MRI and flow and 
metabolite measurement by Dynamic Contrast Enhanced MRI, Arterial Spin Labeling or 
spectroscopic techniques are contributing to our wider understanding of placental function.  
 
Conclusion The future of placental MRI is exciting, with the increasing availability of 
multiple contrasts and new models that will boost the capability of MRI to measure oxygen 
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1 INTRODUCTION 
Magnetic Resonance Imaging (MRI) of the placenta has been part of clinical practice for 
many years, but is most commonly performed to aid in the diagnosis and management of 
abnormally adherent placentation. However, there is a growing field investigating imaging of 
the placenta for other applications (Figure 1). This is down to the technique’s ability to image 
not only structure, but to also provide quantitative measures that relate to the tissue properties 
and function. Several techniques are sensitive to the vascular structure and to properties such 
as oxygenation and blood flow and thus reveal functional information. Combinations of these 
techniques have much to contribute to fetal conditions amenable for therapy such as 
singletons at high risk for Fetal Growth Restriction (FGR) through early recognition, 
appropriate management and monitoring response to treatment; and monochorionic twin 
pregnancies for planning surgery and counselling for selective growth restriction and 
transfusion conditions.  
1.1 FETAL GROWTH RESTRICTION 
Placental insufficiency leads to FGR, where a fetus fails to reach their genetic growth 
potential. Poor fetal nutrition and hypoxia result, with increased risk of cognitive impairment, 
in cerebral palsy and in lifelong metabolic consequences1. The condition is associated with up 
to two thirds of stillbirths in the UK2–4. FGR can be challenging to diagnose as placental 
function cannot currently be directly measured. Surrogate markers, such as abnormal fetal 
growth trajectory, or abnormal blood flow to the placenta5–78 are used with varying success.  
At present there is no treatment for FGR, or the associated condition pre-eclampsia, however 
trials are exploring several new therapeutic avenues, including; sildenafil9, esomeprazole10, 
metformin11, pravastatin12 and vascular endothelial growth factor maternal gene therapy13,14. 
Developing new techniques to assess placental function and response to management is 
therefore essential15–18. 
FGR is typically divided into early and late-onset, most frequently defined as diagnosis 
before or after 32 weeks of gestation5,19,20. These have relatively different clinical 
phenotypes, with early-onset FGR being relatively less common, but with a high incidence of 
placental pathology, and late-onset being more common, but with a variety of aetiologies. 
Clinical challenges in these groups also differ. In early-onset FGR the difficulty is in 
balancing in utero mortality and morbidity against the associated complications of iatrogenic 
preterm birth21–23, whereas in late-onset FGR the primary issue is detection and delineation 
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from normal small fetuses.  Chronic hypoxia is a critical feature of FGR18,24. It is possible 
that measurement of fetal or placental oxygen saturation or oxygen exchange may be useful 
in differentiating the normal small fetus from one with early or late-onset FGR, and might 
predict outcome.  
Placental insufficiency is generally considered to be as a consequence of inadequate spiral 
artery remodeling from insufficient trophoblast invasion in early pregancy25. The most 
common abnormal histological finding is patchy placental infarcts26. Lesions relating to 
hypoxia, and therefore suggestive of reduced maternal perfusion are seen more commonly 
than in normally grown pregnancies. These include syncytiotrophoblast knots, excess 
cytotrophoblast cells, thickened basement membranes, villous fibrosis, and hypovascular 
terminal villi, with reduced villous volume, reduced intervillous space, and non-specific 
inflammatory lesions27. Understanding this pathophysiology is key to timely diagnosis and 
management of FGR. Imaging the placenta is therefore important to our understanding and 
ability to manage FGR15–18. 
 
2 COMPLICATED MONOCHORIONIC TWIN PLACENTAS 
2.1 Twin-to-twin transfusion syndrome 
In monochorionic twin pregnancies the two fetuses are intrinsically linked through 
connections between their circulatory system within the placenta28,29,30,31.  Twin-to-twin 
transfusion syndrome (TTTS) is caused by haemodynamic unbalance through these vascular 
connections32, resulting in one hypovolaemic and one hypervolaemic fetus. If managed 
conservatively the overall survival rate for TTTS is around 30%33. Laser surgery to coagulate 
the anastomosing vessels along the placental equator has been shown to be the most effective 
management option for severe TTTS34. Increasing information on the location of the vascular 
equator, and the flow mismatch between twins may help clinicians in managing these 
pregnancies and in planning intervention. 
 
There are limited studies of the villous structure and microcirculation, so placental vascular 
function is poorly understood.  Histological studies have found no difference in 
histomorphometric variables between shared and non-shared lobules of uncomplicated 
monochorionic pregnancies35,36. In TTTS however, the donor has reduced average terminal 
villous diameter, smaller capillaries, reduced vascularization and larger feto-maternal 
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diffusion distance, compared to the recipient twin35,36, likely due to the haemodynamic 
imbalance between the twins.  
 
2.2 Selective Fetal Growth Restriction 
Selective Fetal Growth Restriction (sFGR) is usually regarded as the combination of one twin 
<10th centile for estimated fetal weight (EFW) and a growth discordance between 
monochorionic twins of greater than 20-25%, and occurs in 7-11% of monochorionic 
pregnancies37–39. It is an important cause of morbidity and mortality40,41. Selective growth 
restriction provides unique challenges to the obstetrician. Premature delivery comes at the 
cost of prematurity for the normally grown twin. In some cases, selective reduction of the 
growth restricted twin is offered in order to optimise the chances for the normally grown 
fetus. Laser surgery to divide the placentas can also be used, to give both fetuses a chance, 
whilst protecting the normally grown fetus from harm should the smaller twin die. There is 
limited information for the clinician on which management option is likely to be the most 
beneficial for any given situation.  
Fetuses with the greater share of the placenta have faster growth velocity than fetuses with 
the smaller share, unless an arterio-venous anastomosis is present with net transfusion 
towards the fetus with the smaller territory which will equalize growth velocities30. 
Additionally the presence of an arterio-arterial anastomosis has been linked to unequal 
growth in twins with unequal placental share, and absence of an arterio-arterial anastomosis 
breaks the association42 although this is thought to have a protective association for TTTS. 
Conversely an increased proportion of arterio-venous anastomoses, although rare, is linked 
with Twin Anemia Polycythemia Sequence (TAPS)43. Thus studies suggests a combination of 
the volume of placental tissue available to each fetus, and the degree and balance of 
transfusion between them, is responsible for the development of selected growth restriction44.   
3 MRI 
3.1 Structural Imaging of placenta size and shape 
The placenta can easily be visualized on MRI, with a clear boundary against the amniotic 
fluid, and a less clear placental-uterine boundary (Figure 2). The entire placenta can be 
imaged at any gestational age, measuring the anatomical size, shape and vascular properties 
across the whole organ. MRI is safe in pregnancy45. T2 weighted structural imaging shows a 
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homogenous structure with relatively high T2 signal intensity, giving it a light grey 
appearance. The T2 value falls in placental insufficiency, giving the placenta a darker 
appearance, with more heterogeneity, possibly due to areas of infarction and fibrosis46. The 
placenta is smaller in FGR compared to normally grown controls, and has a thickened, 
globular appearance47. In twin pregnancies, the two cord locations can be seen, and the larger 
chorionic vessels identified, allowing identification of the vascular equator. Super-resolution 
reconstruction techniques can be used to combine data from 2D stacks acquired in multiple-
planes into a single 3D volume48. This technique has been applied widely to the fetal brain, 
and extensions of this technique, although made substantially more complicated by non-rigid 
motion, are being used for other abdominal organs 49. For placenta size, shape and thickness 
estimation, these techniques are likely to represent the best way to acquire data47,50–54.  3D 
reconstruction of structural MRI data has already been shown to have potential in surgical 
planning for laser division in TTTS55,56, and as imaging and reconstruction techniques 
improve is likely to play an increasingly important role.  
 
3.2 Diffusion Weighted Imaging 
Diffusion Weighted Imaging (DWI) is widespread in all areas of medical MRI. The 
sensitisation of the MRI signal to water movement means that the local tissue structure can be 
measured by changing the parameters of the diffusion pulses. An apparent diffusion 
coefficient (ADC) value is calculated for each voxel within an image, and this is displayed as 
a parametric ADC map (Figure 3a). Voxels with higher ADC values represent a greater 
degree of water diffusion such as within fluid, whereas voxels with low ADC values 
represent restricted and hindered diffusion, such as within cellular tissue. The ADC therefore 
depends on the tissue being imaged, and if pathology is present and thus the accuracy and the 
precision of this value depend on the experimental parameters used57.  
Several studies have looked at DWI of the growth-restricted placenta58,59, with placental 
ADC values being found to be significantly lower in the placentas of FGR pregnancies 
compared to normal controls and in sFGR60. This suggests the micro-architectural 
disturbance in FGR placentas is measurable with MRI. 
When DWI is performed in well perfused vascular tissues, the measured signal attenuation at 
low diffusion sensitisation is not only due to free water diffusion in tissue but also from 
microcirculation within the capillary network61,62. Intra-Voxel Incoherent Motion (IVIM)63 is 
the traditional variant of DWI applied to perfused organs. It can be used in the assessment of 
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capillary flow without the need for injecting contrast agents64. As movement of blood within 
capillaries has no specific orientation and is dependent on the vascular architecture and 
velocity of the blood it is termed pseudodiffusion. The IVIM model has two compartments, 
relating to the solid tissue diffusivity and the tissue perfusion, or pseudodiffusivity. The 
proportion of each signal is given by the perfusion fraction. Naturally the product of this 
perfusion fraction with the pseudodiffusivity is a correlate of blood flow. Although the model 
fitting is prone to noise, several authors have attempted to make fitting more robust65,66,57.  
Surgically reduced uterine blood flow in animal models can be observed with IVIM 
imaging67, and in humans the perfusion fraction has been repeatedly shown to be reduced in 
placental insufficiency compared to normal placentas68,69,70,71. Caution however should be 
applied when interpreting quantitative results from single-contrast MRI which can be 
confounded by choice of other imaging parameters if not held-constant; in both the liver and 
the placenta, quantification of the vascular density is affected by the choice of other image 
acquisition parameters72,73. Specifically it has been found that the estimated perfusion fraction 
in IVIM is dependent on the chosen echo time72. This problem may be overcome using joint 
models, fitting DWI alongside T2 or T2* relaxation measurements70,74. 
Diffusion measurements of this type can be enhanced by including directional 
sensitisation66,75 and this has been used frequently in other organs to reveal the organisation 
of the tissue structure, especially the brain76. In the placenta the directional sensitivity might 
reveal information about the structure of the villous tree and how this changes in pathology 
such as FGR where insufficient spiral artery re-modelling is thought to lead to mechanical 
damage and immaturity in the fetal villous tree which may reduce the measured diffusion of 
water. In the human haemomonochorial placenta the technique may be limited by in vivo 
motion and pulsatility in contrast to the complicated structural exchange interfaces seen in 
other mammals. The technique is also, in principle, sensitive to water perfusion. There is now 
some evidence of directionality in flow in the placenta, particularly near to the chorionic 
plate66 and this is likely to be associated with net differences in flow properties between 
chorionic arteries and veins.   
Although to date most research has been performed investigating singleton growth restriction, 
in the future perfusion imaging may be useful to quantify placental perfusion mis-match 
between twins, and the functional volume of placental tissue. This may guide the best 
location for laser coagulation, ensuring each twin has sufficient functioning tissue to survive, 
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or demonstrate that this is not possible, making selective reduction the safest management 
option.  
3.3 Relaxometry 
Relaxometry is the measurement of the signal decay rate in MR by both longitudinal (T1) and 
transverse (T2/T2*) decay. These contrasts can be explored independently by careful choice 
of pulse sequence. Theoretically, if not practically, these times correspond to independent 
physical properties of the tissue.  
T2 relaxometry is the quantitative measure of hydrogen proton relaxation following 
excitation with a radio frequency pulse. The rate of relaxation is different for each tissue; 
tissue has a short T2 relaxation time, whilst blood has a much longer T2 relaxation time77,78 
(Figure 3b). Tissues with greater all over surface area, whether in the form of cellular 
membranes or intracellular or extracellular fibrillary macromolecules, tend to have shorter T2 
values. In the placenta T2 relaxation time decreases with increasing gestation79, possibly 
because of the proportional increase in villous tissue compared to intervillous space, and 
increasing fibrin volume density80. T2 relaxation times are significantly reduced in placentas 
from pregnancies complicated by FGR compared to those with appropriate growth, possibly 
due to increases in fibrosis, necrosis and infarcts within the placental parenchyma81–84 and 
reduced fetal oxygen saturation24,85.  
T2 values are dominated by the level of oxygen saturation78,86,87, higher oxygen saturation 
values result in higher T2 values. MRI may provide a useful indirect measurement for feto-
placental oxygenation since oxygen saturation is difficult to measure directly and invasive 
methods carry a risk of miscarriage. MRI relaxometry provides a non-invasive way to 
measure feto-placental oxygen levels, that has been partially validated in sheep88,89. Oxygen 
saturation in the feto-placental system is typically quite low when compared to healthy adult 
measures of oxygen saturation and is found to be significantly lower in growth restricted 
fetuses24,90.  
Blood Oxygenation Level Dependent (BOLD) MRI is a T2*-weighted sequence that is able 
to detect changes in the proportion of deoxyhaemoglobin, and hence reflects tissue oxygen 
saturation. This technique has found much use for mapping brain function where spatial 
patterns are used to understand functional networks91,92, but is increasingly finding other 
applications outside of the brain for its ability, in combination with other flow measurements, 
to measure oxygen extraction and thus efficiency93. However, the interpretation of the 
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placental BOLD signal is complex, with signal changes dependent on other factors including; 
blood flow, blood volume fraction and haematocrit82,94,95.  
BOLD and T2* measurements are often conflated in the literature. The T2* value cannot be 
directly related to tissue oxygenation as tissue morphology also affects the T2* value, with a 
reduction in T2* of the placenta with increasing gestation96 (Figure 4). This gestational 
relationship may be related to the histological maturation of the placenta, and the decrease in 
placental oxygenation as pregnancy advances97. During a maternal oxygen-challenge 
(hyperoxia) the difference in the absolute T2* value (T2*) signals the change in placental 
oxygenation independent of baseline conditions, thus demonstrating tissue oxygen saturation.  
Changes in BOLD signal with controlled hyperoxia and in FGR have been demonstrated in 
the placenta and other fetal organs98,99. However, a difference in T2* has not been 
demonstrated in cases of placental dysfunction related to FGR to date despite conflicting 
animal data82,100–102.    
  
In T1-weighted Oxygen-Enhanced (OE) MRI100,103,104 the signal change related to the 
maternal oxygen-challenge reflects changes in tissue pO2, due to the paramagnetic properties 
of dissolved oxygen. Compared to BOLD, the absolute signal change seen in OE MRI 
declines with gestational age and is significantly lower in pregnancies with fetal growth 
restriction100,103. This is thought to support the theory of a relative placental hypoxia in FGR 
related to placental dysfunction, as more of the dissolved oxygen becomes bound to 
deoxyhaemoglobin, and hence less becomes dissolved within the tissue.  
 
The potential to estimate fetal oxygen saturations non-invasively has obvious potential in the 
management of singleton and twin growth restriction. It could inform on response to 
treatment, and also on timing of delivery and might relate to placental function, allowing 
assessment of each lobule of the placenta. The dependence of T2 on haematocrit may also be 
useful in assessment of TTTS, and if TAPS is suspected.  
3.4 Multi-compartment multi-contrast models  
Conventional T1, T2 and T2* relaxometry are limited having no physiological correlate 
outside of MRI and an often unknown or intractable dependence on physiological properties 
of interest such as blood flow, saturation, haematocrit or cellular composition. Pure tissue 
regions such as fluid can sometimes be used to infer properties directly105 but these are more 
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often the exception rather than the rule. Most regions of tissue within an imaging voxel will 
be mixed, particularly in the heterogenous placenta where fetal blood, maternal blood and 
tissue are present within any given voxel. Using joint acquisition protocols it can be possible 
to separate the signal contributions from different tissue types72–74. This approach does allow 
physiological properties of the tissue to be inferred; providing the window for potential 
histological, complementary or invasive validation methods.  
Multi-compartment multi-contrast models of the type used in DWI can also be generated. The 
first multicompartment placental specific model is DECIDE73, which separates the different 
T2 values of fetal and maternal blood from the background tissue compartment (Figure 5). 
Doing this results in a mechanism, under certain assumptions, to measure the fetal blood 
oxygen saturation. This model can also be applied to combined DWI and T2* data. Multi-
contrast models of this type represent a paradigm shift in the use of MRI for FGR, giving a 
non-invasive measurement of placental function73,74. Models such as these carry their own 
assumptions about the physics and physiology of the signal generation process and so 
researchers should be aware of the limitations of each model for specific pathologies. In 
general, they carry the same goal of scanner-independence as for single-compartment models 
of T2 or diffusivity, in principle allowing the combination and comparison of data between 
sites and populations, but additionally allowing further validation work because of their 
physical motivation. 
3.5 MRI Flow and Metabolic Measurement 
A key area of MR research is the measurement of the vascular properties of a tissue. The 
gold-standard technique for this uses an injected para-magnetic contrast agent that makes it 
unsuitable for fetal and maternal clinical MRI except in the most extreme 
circumstances106,107. Dynamic Contast Enhanced (DCE) MRI81,89 does have the capability to 
reveal the pharmaocokinetics of the placenta including the input of blood to the uterus and 
placenta and the exchange of contrast agent into the trophoblast and across to the fetus 
(Figure 6). Common models describe the delivery of contrast to the maternal side of the 
placenta and the transfer of contrast agent into the fetal blood pool, thus having the potential 
to improve our understanding of how these processes are affected in different 
pathologies107,110,111. However, the decision to use contrast to image complex pregnancies is 
challenging.  
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Flow can be measured with phase contrast MRI, an imaging technique that encodes the blood 
flow velocity in large arteries, typically of several millimetres in diameter, directly into the 
MR imaging data. In combination with knowledge of the vessel area this gives a quantitative 
estimate of blood flow112,113. Due to the readily available use of Doppler ultrasound there is 
little work in this area114,115. 
Arterial Spin Labeling is a further imaging technique that magnetically labels blood water to 
visualise larger arterial vessels and blood perfusion68,116,117. Arterial blood water is 
magnetically labelled just below the region of interest using a radiofrequency inversion pulse. 
This magnetised tracer flows into the slice of interest, reducing the total tissue magnetisation, 
and consequently reducing the MR signal and image intensity. The difference between a 
labelled and un-labelled control image provides a measure of perfusion118. ASL is exquisitely 
sensitive to motion and can be relatively time consuming to acquire due to the low average 
signal. However, its key strength is the ability to acquire multiple different labels with 
differing post-label delays or different velocity encodings, thus revealing much about the 
dynamic perfusion of the placenta. A comparison of IVIM and ASL to assess placental 
perfusion in the second trimester in normal and FGR pregnancies showed a significant 
reduction in basal plate ASL signal between normally grown and FGR pregnancies. Basal 
plate, central placental and whole placental IVIM vascular density was also different between 
normally grown and FGR pregnancies68. As with IVIM, this technique could be useful in 
monitoring response to treatment in FGR placentas, and also perfusion differences in twin 
pregnancies. The benefit of this technique is that it is a more direct measurement of 
perfusion, however it is challenging to apply in practice.  
Placenta metabolites can be measured in principle using MRI via proton magnetic resonance 
spectroscopy which has been investigated in the placenta. However, high acquisition failure 
rates and difficulty in interpreting the signal mean this is a relatively immature technique 
within the placenta119,120. 
Lastly, although to the best of our knowledge it has not yet been tested in humans, 
hyperpolarised MRI represents a unique way to assess the placental barrier and its metabolic 
behavior and permeability121. The use of different hyperpolarized metabolites could reveal a 
range of information on different pathways and pathology far beyond that obtained from 
pharmacokinetic studies of Gadolinium chelates or other heavy contrast molecules. 
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4 CONCLUSION 
The ability of MRI to detect changes in placentas of severely growth restricted fetuses with 
abnormal Doppler’s is well established71,79,81,96. However, the ability of MRI to measure 
placental function more broadly has yet to be fully realized or investigated. With further 
development, MRI is likely to increase our understanding of abnormal placental function, 
improve diagnostic accuracy, and help guide intervention and monitor response.  The 
advances currently being made in the examination of placentas from pregnancies affected by 
growth restriction will find application in wider conditions such as complicated twin 
pregnancies, invasive placentation, chorioangioma, caesarean scar pregnancies and the 
function of other fetal organs.   
One of the limitations to the practical use of placental MRI is the relative rarity of some of 
the conditions being investigated. This can make it difficult to establish studies with 
sufficient numbers to fully investigate new imaging techniques and hence make 
recommendations about clinical practise. Enhanced coordination of studies between centres 
and the sharing of clinical and technical expertise alongside imaging data are essential when 
investigating these conditions122 and will help to establish the most useful imaging 
technologies for each pathology. This will speed up the pace of future feto-placental research 
for conditions that, for the ubiquity of pregnancy remain quite rare but have lifelong impact. 
The future of placental MRI is exciting, the use of multiple contrasts and new models to 
boost the capability of MRI to measure oxygen saturation73 and placental exchange107,121 will 
enhance the understanding of  placental function in complicated pregnancies.  
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Figure 1. Use of MRI in human placental conditions other than accreta, papers discussed in 
this review. Abbreviations in text. 
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Figure 2. MRI of placenta from a normally grown (left) and FGR (right) fetus. The placenta 
are marked with white stars. Note the difference in appearance inT2 weighted imaging, with 
the normal placenta appearing lighter in colour and more homogeneous. 
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Figure 4. T2 weighted structural image of axial slice through maternal abdomen, 
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Figure 5. Physiological model-fitting of the placenta73. Parametric maps can be produced 
corresponding to fetal and maternal perfusion fractions (bottom row) simultaneously to 
conventional ADC and T2 maps (top row). 
  
 
This article is protected by copyright. All rights reserved. 
 
 
Figure 6. Dynamic enhancement of the placenta with DCE-MRI. Baseline image (1), arrival 
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Table 1 Future applications of MRI in placental conditions amenable to therapy 
 
Technique MRI signal sensitivity Future applications 
T2weighted 
Structural features, fluid boundaries, 
volumetrics 
Placental share in complicated twins, cord insertions, 
chorionic vessel mapping, computer assisted surgical 
planning 
DWI 
Diffusivity, micro-architecture, fluid 
not specific to oxygenation/flow. 
Micro-vascular structural differences in FGR/PET/sFGR 
IVIM 
Diffusivity, micro-vasculature, fluid, 
perfusion. Chorionic flow. Non-specific 
to oxygenation 
Functional share in complicated twins. Flow changes in 
FGR. Post-intervention redistribution + outcome 
prediction. 
T2weighted 
Sensitive to oxygenation, tissue 
compartments 
Changes in fetal oxygenation functional redundancy and 
capacity 
T2* 
Sensitive to oxygenation, tissue 
compartments 
Changes in fetal oxygenation, functional redundancy 
and capacity  
BOLD 
Sensitive to functional change in 
oxygenation 
Changes in function, and tissue redundancy and 
capacity over time 
T1 Sensitive to oxygenation 
Maternal blood flow changes in FGR. Redistribution 
post-laser TTTS 
MRS & metabolic Transfer rates, tissue maturation Therapeutic changes in transfer and exchange 
ASL Sensitive to flow and perfusion Maternal blood flow changes in FGR. Redistribution 
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post-laser TTTS 
DCE Sensitive to flow and transfer rate Changes in maternal flow and transfer kinetics. 
 
